Boris Pasche/LinkedIn
Apr 12, 2025, 14:52
Boris Pasche leads the team to deliver the Karmanos Advantage to every patient – Karmanos Cancer Institute
Karmanos Cancer Institute shared a post on LinkedIn:
“We couldn’t wait to take part in this trend…introducing our President and CEO, Boris Pasche! Researcher, medical oncologist, and co-inventor of the TheraBionic Inc. P1 Device.
Complete with your cancer care team essentials and ready to lead our team of specialists dedicated to delivering the Karmanos Advantage to every patient.”
Boris Pasche, President and CEO of Karmanos Cancer Institute, shared this post adding a comment:
“A big Thank You to Karmanos marketing team for this fun Friday creation!”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 14, 2025, 14:42
Apr 14, 2025, 14:30
Apr 14, 2025, 13:49
Apr 14, 2025, 13:47
Apr 14, 2025, 13:40
Apr 14, 2025, 13:36
Apr 14, 2025, 13:31
Apr 14, 2025, 13:19